CMS CMS Issues New Guidance on Independent Dispute Resolution Process Thomas Sullivan Jun 6, 2022 0 On April 14, 2022, the Centers for Medicare & Medicaid Services (CMS) issued new guidance on the Independent Dispute…
CMS CMS to Finalize Medicare Proposal Regarding Aduhelm Thomas Sullivan Jun 3, 2022 0 The Centers for Medicare and Medicaid Services announced that it will finalize its proposal for Medicare to cover Aduhelm and…
FDA FDA Issues Draft Guidance Focused on Clinical Trial Diversity Thomas Sullivan Jun 2, 2022 0 The US Food and Drug Administration is recommending sponsors include a plan to increase diversity when proposing clinical trial…
Congress Pharmacy Benefit Manager Transparency Act of 2022 Introduced Thomas Sullivan Jun 1, 2022 0 On May 24, 2022, a bipartisan duo of Senators introduced legislation to crack down on certain pharmacy benefit manager (PBM)…
CME Massachusetts to Require CME Credit on Implicit Bias in Health Care Thomas Sullivan May 31, 2022 0 Beginning June 1, 2022, the Massachusetts Board of Registration in Medicine (BORIM) will require that both applicants for initial…
Events The Transparency and Aggregate Spend Virtual Summit Scheduled for June 27th… Thomas Sullivan May 31, 2022 0 The Transparency and Aggregate Spend Virtual Summit is scheduled for June 27th and 28th, 2022. The conference chair is Kelly Tope,…
DOJ Hearing Aid Company Agrees to $34 Million Settlement Over False Claims Act… Thomas Sullivan May 27, 2022 0 Earlier this year, Eargo Inc. agreed to a $34.37 settlement with the United States Department of Justice (DOJ) over allegations…
DOJ DOJ Reaches $22.7 Million Settlement with Providence Over Medically… Thomas Sullivan May 26, 2022 0 In mid-April 2022, the United States Department of Justice (DOJ) announced a $22,690,458 settlement with Providence Health &…
State Policy New York is the Latest State to Allow Full Practice Authority for Nurse… Thomas Sullivan May 25, 2022 0 On April 11, 2022, New York Governor Kathy Hochul signed the state budget into law, which includes reforms surrounding services…
FDA Bausch Health Receives Untitled Letter from OPDP Over Statements Made on… Thomas Sullivan May 24, 2022 0 On March 31, 2022, the United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent an…